190 related articles for article (PubMed ID: 9108410)
1. Hyaluronate-CD44 interactions can induce murine B-cell activation.
Rafi A; Nagarkatti M; Nagarkatti PS
Blood; 1997 Apr; 89(8):2901-8. PubMed ID: 9108410
[TBL] [Abstract][Full Text] [Related]
2. Role of CD44 and hyaluronic acid (HA) in activation of alloreactive and antigen-specific T cells by bone marrow-derived dendritic cells.
Do Y; Nagarkatti PS; Nagarkatti M
J Immunother; 2004; 27(1):1-12. PubMed ID: 14676629
[TBL] [Abstract][Full Text] [Related]
3. LPS regulation of the immune response: separate mechanisms for murine B cell activation by lipid A (direct) and polysaccharide (macrophage-dependent) derived from Bacteroides LPS.
Williamson SI; Wannemuehler MJ; Jirillo E; Pritchard DG; Michalek SM; McGhee JR
J Immunol; 1984 Nov; 133(5):2294-300. PubMed ID: 6332842
[TBL] [Abstract][Full Text] [Related]
4. Mouse B cell activation is inhibited by CD44 cross-linking.
Wyant TL; Fisher MT; McKallip RJ; Nagarkatti PS; Nagarkatti M; Conrad DH
Immunol Invest; 2005; 34(4):399-416. PubMed ID: 16304729
[TBL] [Abstract][Full Text] [Related]
5. Characterization of CD44-mediated hyaluronan binding by renal tubular epithelial cells.
Oertli B; Fan X; Wüthrich RP
Nephrol Dial Transplant; 1998 Feb; 13(2):271-8. PubMed ID: 9509434
[TBL] [Abstract][Full Text] [Related]
6. CD44 plays a co-stimulatory role in murine T cell activation: ligation of CD44 selectively co-stimulates IL-2 production, but not proliferation in TCR-stimulated murine Th1 cells.
Sommer F; Huber M; Röllinghoff M; Lohoff M
Int Immunol; 1995 Nov; 7(11):1779-86. PubMed ID: 8580076
[TBL] [Abstract][Full Text] [Related]
7. Induction of IL-12 and chemokines by hyaluronan requires adhesion-dependent priming of resident but not elicited macrophages.
Hodge-Dufour J; Noble PW; Horton MR; Bao C; Wysoka M; Burdick MD; Strieter RM; Trinchieri G; Puré E
J Immunol; 1997 Sep; 159(5):2492-500. PubMed ID: 9278343
[TBL] [Abstract][Full Text] [Related]
8. LPS regulation of the immune response: Bacteroides endotoxin induces mitogenic, polyclonal, and antibody responses in classical LPS responsive but not C3H/HeJ mice.
Wannemuehler MJ; Michalek SM; Jirillo E; Williamson SI; Hirasawa M; McGhee JR
J Immunol; 1984 Jul; 133(1):299-305. PubMed ID: 6202784
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronate receptors mediating glioma cell migration and proliferation.
Akiyama Y; Jung S; Salhia B; Lee S; Hubbard S; Taylor M; Mainprize T; Akaishi K; van Furth W; Rutka JT
J Neurooncol; 2001 Jun; 53(2):115-27. PubMed ID: 11716065
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune response.
Lesley J; Howes N; Perschl A; Hyman R
J Exp Med; 1994 Jul; 180(1):383-7. PubMed ID: 7516415
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronan-dependent motility of B cells and leukemic plasma cells in blood, but not of bone marrow plasma cells, in multiple myeloma: alternate use of receptor for hyaluronan-mediated motility (RHAMM) and CD44.
Masellis-Smith A; Belch AR; Mant MJ; Turley EA; Pilarski LM
Blood; 1996 Mar; 87(5):1891-9. PubMed ID: 8634437
[TBL] [Abstract][Full Text] [Related]
12. Oligosaccharides of hyaluronan are potent activators of dendritic cells.
Termeer CC; Hennies J; Voith U; Ahrens T; Weiss JM; Prehm P; Simon JC
J Immunol; 2000 Aug; 165(4):1863-70. PubMed ID: 10925265
[TBL] [Abstract][Full Text] [Related]
13. Angiogenic oligosaccharides of hyaluronan induce protein tyrosine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation.
Slevin M; Krupinski J; Kumar S; Gaffney J
Lab Invest; 1998 Aug; 78(8):987-1003. PubMed ID: 9714186
[TBL] [Abstract][Full Text] [Related]
14. Glycosylation of CD44 negatively regulates its recognition of hyaluronan.
Katoh S; Zheng Z; Oritani K; Shimozato T; Kincade PW
J Exp Med; 1995 Aug; 182(2):419-29. PubMed ID: 7543137
[TBL] [Abstract][Full Text] [Related]
15. Potential role for hyaluronan and the hyaluronan receptor RHAMM in mobilization and trafficking of hematopoietic progenitor cells.
Pilarski LM; Pruski E; Wizniak J; Paine D; Seeberger K; Mant MJ; Brown CB; Belch AR
Blood; 1999 May; 93(9):2918-27. PubMed ID: 10216086
[TBL] [Abstract][Full Text] [Related]
16. Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells.
Galluzzo E; Albi N; Fiorucci S; Merigiola C; Ruggeri L; Tosti A; Grossi CE; Velardi A
Eur J Immunol; 1995 Oct; 25(10):2932-9. PubMed ID: 7589094
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal anti-CD44 antibody acts in synergy with anti-CD2 but inhibits anti-CD3 or T cell receptor-mediated signaling in murine T cell hybridomas.
Guo YJ; Ma J; Wong JH; Lin SC; Chang HC; Bigby M; Sy MS
Cell Immunol; 1993 Nov; 152(1):186-99. PubMed ID: 7694807
[TBL] [Abstract][Full Text] [Related]
18. Regulation of interleukin-2-induced vascular leak syndrome by targeting CD44 using hyaluronic acid and anti-CD44 antibodies.
Mustafa A; McKallip RJ; Fisher M; Duncan R; Nagarkatti PS; Nagarkatti M
J Immunother; 2002; 25(6):476-88. PubMed ID: 12439345
[TBL] [Abstract][Full Text] [Related]
19. CD3-mediated T cell activation is inhibited by anti-CD44 monoclonal antibodies directed to the hyaluronan-binding region.
Sugiyama K; Komada Y; Deguchi T; Zhang XL; Azuma E; Ido M; Yamamoto H; Sakurai M
Immunol Invest; 1999; 28(2-3):185-200. PubMed ID: 10484683
[TBL] [Abstract][Full Text] [Related]
20. CD44 expression on activated B cells. Differential capacity for CD44-dependent binding to hyaluronic acid.
Hathcock KS; Hirano H; Murakami S; Hodes RJ
J Immunol; 1993 Dec; 151(12):6712-22. PubMed ID: 7505013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
